Published in Blood Weekly, October 27th, 2005
Study 1: The use of sirolimus-eluting stents (SESs) improves the outcome of primary angioplasty in heart attack patients.
SESs "are currently being used in patients undergoing percutaneous coronary intervention (PCI)," but "have not been evaluated in the treatment of acute myocardial infarction (AMI) by primary angioplasty," cardiologists in the United States explained.
In a report published in the journal Catheterization and Cardiovascular Interventions, E. Cheneau and coauthors at the Washington Hospital Center in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.